glp 1 deficiency Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society Impact of GLP- 1 Receptor

Efficacy and Safety of Glucagon-Like Peptide-1/Glucagon Receptor Co-Agonist JNJ-64565111 in Individuals With Obesity Without Type 2 Diabetes Mellitus: A Randomized Dose-Ranging Study

A species comparison of liver slice synthesis and secretion of triacylglycerol from nonesterified fatty acids in media

Adult cartilage shows declining cellularity, accumulated matrix damage, reduced proteoglycan content, calcification advancement

In the UK, GLP-1 receptor agonists are primarily prescribed for two main indications : type 2 diabetes mellitus and weight management in adults with obesity or overweight with weight-related comorbidities